Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey

被引:25
作者
Chiang, Tom [2 ]
Mariano, Noriel [1 ,3 ]
Urban, Carl [1 ,3 ]
Colon-Urban, Rita [4 ]
Grenner, Louise [1 ,3 ]
Eng, Robert H. K. [2 ]
Huang, David [2 ]
Dholakia, Hema [2 ]
Rahal, James J. [1 ,3 ]
机构
[1] New York Hosp Queens, Flushing, NY 11355 USA
[2] Vet Affairs New Jersey Hlth Care Syst, E Orange, NJ USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] SUNY Coll Old Westbury, Old Westbury, NY 11568 USA
关键词
D O I
10.1089/mdr.2007.767
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Klebsiella pneumoniae isolates harboring KPC enzymes have been identified in many geographical areas since 2001. Numerous problems exist in the detection and treatment of patients with such isolates. The clinical characteristics and molecular epidemiology associated with 12 randomly chosen patients in whom these enzymes were detected by molecular methods are described. This is the first description of the identification of carbapenem-resistant K. pneumoniae isolates harboring KPC beta-lactamases at the Veterans Administration Hospital in New Jersey (VA NJHCS). Because recognition of carbapenem resistance in K. pneumoniae due to KPC enzymes can only be achieved by molecular methods, detection in the Clinical Microbiology Laboratory by routine methods will continue to be difficult, leading to dilemmas in treatment.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 20 条
[1]   Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States [J].
Alvarez, M ;
Tran, JH ;
Chow, N ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :533-537
[2]   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City [J].
Bradford, PA ;
Bratu, S ;
Urban, C ;
Visalli, M ;
Mariano, N ;
Landman, D ;
Rahal, JJ ;
Brooks, S ;
Cebular, S ;
Quale, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :55-60
[3]   Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein [J].
Bradford, PA ;
Urban, C ;
Mariano, N ;
Projan, SJ ;
Rahal, JJ ;
Bush, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :563-569
[4]   Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents [J].
Bratu, S ;
Tolaney, P ;
Karumudi, U ;
Quale, J ;
Mooty, M ;
Nichani, S ;
Landman, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :128-132
[5]   Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium [J].
Bratu, S ;
Landman, D ;
Haag, R ;
Recco, R ;
Eramo, A ;
Alam, M ;
Quale, J .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1430-1435
[6]   Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York:: Epidemiology and recommendations for detection [J].
Bratu, S ;
Mooty, M ;
Nichani, S ;
Landman, D ;
Gullans, C ;
Pettinato, B ;
Karumudi, U ;
Tolaney, P ;
Quale, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :3018-3020
[7]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[8]  
*CLIN LAB STAND I, 2005, 16 INF S
[9]  
FANA C, 2005, 45 INT C ANT AG CHEM
[10]   The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York [J].
Lomaestro, BM ;
Tobin, EH ;
Shang, WC ;
Gootz, T .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (03) :E26-E28